查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球無創產前檢測 (NIPT) 市場：按產品/服務、方法和最終用戶 - 預測（至 2029 年）
市場調查報告書
商品編碼
1549396

全球無創產前檢測 (NIPT) 市場：按產品/服務、方法和最終用戶 - 預測（至 2029 年）

Non-invasive Prenatal Testing (NIPT) Market by Product & Service (Consumables (Assay Kits & Reagents), Instruments (NGS Systems, Microarrays)), Method (Biochemical Screening, Cell-free DNA Test), End User (Diagnostic Labs) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 371 Pages | 訂單完成後即時交付

價格

全球非侵入性產前檢測（NIPT）市場規模預計將從2024年的72億美元增加到2029年的141億美元，複合年成長率為14.5%。

全球無創產前檢測 (NIPT) 市場的公司採取了各種策略來擴大其全球足跡並增加其市場佔有率，例如合作夥伴關係、協議、剝離、擴張和收購。

調查範圍
調查年份 2021-2029
基準年 2023年
預測期 2024-2029
單元 10億美元
部分 按產品/服務、方法、應用程式和最終用戶
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

“服務領域佔據了市場第二大市場佔有率。”

這是由於越來越傾向於將複雜的診斷程序外包給專業服務供應商。這些提供者提供先進的技術和專業知識，以確保準確和及時的結果。此外，服務供應商通常擁有處理大量測試的基礎設施，這對醫療機構來說比維持內部能力更具成本效益。這些外包趨勢顯著提高了 NIPT 市場服務領域的市場佔有率。

“母體血漿 cfDNA 檢測市場預計將表現出最高的複合年成長率。”

這主要是由於其高精度和安全性。與羊膜穿刺術等傳統侵入性手術不同，cfDNA 檢測只需從母親體內抽取血液即可，從而最大限度地減少母親和胎兒的風險。這種非侵入性方法可以在懷孕早期以高靈敏度和特異性檢測多種遺傳狀況，幫助醫療保健提供者和未來的孩子尋求可靠、低風險的產前篩檢選擇，越來越多的親生父母採用這種方法。

“微缺失症候群市場佔據第二大市場佔有率。”

微缺失症候群涉及小染色體片段的缺失，可導致新生兒嚴重的發育缺陷和健康問題。因此，越來越多的準父母選擇 NIPT 來及早發現這些情況，並進行更好的準備和管理。此外，NIPT 為傳統診斷方法提供了一種安全、非侵入性的替代方案，進一步促進了其採用。

“診斷實驗室市場佔據了最大的市場佔有率。”

以最終用戶類型分類，診斷實驗室領域憑藉其先進的技術力和基礎設施能夠實現準確、高效的測試，在市場上佔有最大的市場佔有率。這些實驗室配備了最先進的設備和專業人員，以確保高品質的結果。此外，他們通常與醫療保健提供者和保險公司建立了關係，簡化了患者和醫生的流程。卓越技術、專業知識和簡化業務的整合使 Diagnostic Laboratories 成為 NIPT 的首選，並確保了該領域最大的市場佔有率。

本報告研究和分析了全球非侵入性產前檢測 (NIPT) 市場，提供了包括關鍵促進因素和限制因素、競爭格局和未來趨勢等資訊。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

  • 無創產前檢測（NIPT）市場概述
  • 歐洲無創產前檢測 (NIPT) 市場：按應用分類
  • 區域構成：非侵入性產前檢測（NIPT）市場（2024-2029）
  • 非侵入性產前檢測（NIPT）市場：新興市場與已開發市場（2024/2029）

第5章市場概況

  • 介紹
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 產業趨勢
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 價值鏈分析
  • 生態系分析
  • 供應鏈分析
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 監管環境
    • 監管分析
    • 監管機構、政府機構和其他組織
  • 專利分析
  • 貿易分析
  • 價格分析
    • 平均銷售價格趨勢：依產品分類
    • 平均銷售價格趨勢：按地區
  • 報銷分析
  • 重大會議和活動（2024-2025）
  • 未滿足的需求/最終用戶的期望
  • 案例研究
  • 鄰近市場分析
  • 投資金籌措場景
  • 影響客戶業務的趨勢/干擾
  • 人工智慧對非侵入性產前檢測 (NIPT) 市場的影響

第6章 非侵入性產前檢測 (NIPT) 市場：按產品和服務分類

  • 介紹
  • 產品
    • 消耗品
    • 裝置
  • 服務

第7章 非侵入性產前檢測 (NIPT) 市場：依方法論

  • 介紹
  • 超音波檢測
  • 生化篩檢試驗
  • 母體血漿cfDNA檢測

第8章 非侵入性產前檢測 (NIPT) 市場：按應用分類

  • 介紹
  • 三體性
  • 微缺失症候群
  • 其他用途

第 9 章 非侵入性產前檢測 (NIPT) 市場：依最終用戶分類

  • 介紹
  • 診斷實驗室
  • 醫院

第 10 章 非侵入性產前檢測 (NIPT) 市場：按地區

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲
    • 中東和非洲的宏觀經濟前景
    • 海灣合作理事會國家
    • 其他中東/非洲

第11章競爭格局

  • 概述
  • 主要企業策略/主要企業
  • 收益分析
  • 市場佔有率分析
  • 主要企業研發費用
  • 企業評價矩陣：主要企業（2023年）
  • 企業評估矩陣：Start-Ups/中小企業（2023）
  • 評價及財務指標
  • 品牌/產品比較分析
  • 競爭場景

第12章 公司簡介

  • 主要企業
    • ILLUMINA, INC.
    • NATERA, INC.
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • EUROFINS SCIENTIFIC
    • F. HOFFMANN-LA ROCHE AG
    • REVVITY, INC.
    • THERMO FISHER SCIENTIFIC INC.
    • AGILENT TECHNOLOGIES
    • GE HEALTHCARE TECHNOLOGIES INC.
    • QUEST DIAGNOSTICS INCORPORATED
    • SONIC HEALTHCARE LIMITED
    • CENTOGENE NV
    • QIAGEN NV
    • PATHWEST LABORATORY MEDICINE WA
    • MYRIAD GENETICS, INC.
  • 其他公司
    • BGI GENOMICS CO., LTD.
    • OXFORD NANOPORE TECHNOLOGIES PLC
    • MEDGENOME
    • NEUBERG DIAGNOSTICS
    • ANNOROAD GENE TECHNOLOGY
    • NEXT BIOSCIENCES
    • LILAC INSIGHTS
    • INVITAE CORPORATION
    • BAYLOR GENETICS
    • RAVGEN

第13章附錄

Product Code: BT 5140

The global non-invasive prenatal testing (NIPT) market is projected to reach USD 14.1 billion by 2029 from USD 7.2 billion in 2024 at a CAGR of 14.5%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2021 and June 2024. Players in the global non-invasive prenatal testing (NIPT) market have employed various strategies to expand their global footprint and increase their market shares such as partnerships, agreements, divestitures, expansions, and acquisitions.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsProduct & Service, Method, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa

"The Service segment accounted for the second-largest market share in the non-invasive prenatal testing (NIPT) market."

By products & service, service segment holds the second largest market share in the non-invasive prenatal testing (NIPT) market due to the growing preference for outsourcing complex diagnostic procedures to specialized service providers. These providers offer advanced technology and expertise, ensuring accurate and timely results, which are crucial for expectant parents making informed decisions about their pregnancies. Additionally, service providers often have the infrastructure to handle high volumes of tests, which can be more cost-effective for healthcare facilities than maintaining in-house capabilities. This outsourcing trend drives the substantial market share held by the service segment in the NIPT market.

"cfDNA in maternal plasma test segment of the non-invasive prenatal testing (NIPT) market is expected to witness the fastest CAGR."

By method type, the cfDNA in maternal plasma test segment has witnessed the fastest growth rate in the non-invasive prenatal testing (NIPT) market. This is largely due to its high accuracy and safety. Unlike traditional invasive methods such as amniocentesis, cfDNA testing involves a simple blood draw from the mother, minimizing risk to both the mother and the fetus. This non-invasive approach can detect a wide range of genetic conditions early in pregnancy with high sensitivity and specificity, leading to increased adoption by healthcare providers and expectant parents seeking reliable, low-risk prenatal screening options.

"The Microdeletion syndrome segment of the non-invasive prenatal testing (NIPT) market accounted for the second largest market share."

Based on application type, the microdeletion syndrome segment has accounted for the second largest market share in the Non-invasive Prenatal Testing (NIPT) market primarily due to the increasing awareness and advancements in genetic testing technologies. Microdeletion syndromes, which involve the deletion of small chromosome segments, can lead to significant developmental disorders and health issues in newborns. As a result, expectant parents are increasingly opting for NIPT to detect these conditions early, allowing for better preparedness and management. Moreover, NIPT offers a safe, non-invasive alternative to traditional diagnostic methods, further driving its adoption.

"Diagnostic laboratories segment of the non-invasive prenatal testing (NIPT) market holds the largest market share."

By end user type, the diagnostic laboratories segment has accounted for the largest market share, in the non-invasive prenatal testing (NIPT) market, due to their advanced technological capabilities and infrastructure, which enable accurate and efficient testing. These laboratories are equipped with cutting-edge equipment and specialized personnel, ensuring high-quality results. Additionally, they often have established relationships with healthcare providers and insurance companies, streamlining the process for patients and physicians. This integration of superior technology, expertise, and streamlined operations makes diagnostic laboratories the preferred choice for NIPT, thereby securing the largest market share in this segment.

"APAC region to have the third largest market share in the non-invasive prenatal testing (NIPT) market, by region."

In the APAC region, the non-invasive prenatal testing (NIPT) market has grown significantly. This is mainly because of the region's rapidly growing population and increasing awareness of prenatal health. With countries like China and India having large and expanding populations, there is a heightened demand for advanced prenatal testing solutions. The growing middle class in these countries is also becoming more health-conscious and willing to invest in high-quality healthcare services, including non-invasive prenatal testing. Additionally, the rising incidence of advanced maternal age and a greater emphasis on early disease detection further drive the demand for NIPT. These factors collectively contribute to APAC's leading position in the global market for non-invasive prenatal testing.

A breakdown of the primary participants (supply side) for the non-invasive prenatal testing (NIPT) market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-25%, and Tier 3-40%
  • By Designation: C-level-45%, Director Level-25%, and Others-30%
  • By Region: North America-36%, Europe-26%, Asia Pacific-21%, Latin America-10%, and Middle East & Africa_ 7%

A breakdown of the primary participants (demand side) for the non-invasive prenatal testing (NIPT) market refer to for the report is provided below:

  • By End User Type: Diagnostic Laboratory-65%, Hospitals-35%
  • By Designation: Laboratories Technicians-55%, Doctor-45%
  • By Region: North America-34%, Europe-27%, Asia Pacific-23%, Latin America-9%, and Middle East & Africa-7%

Key Market Players:

The prominent players in the non-invasive prenatal testing (NIPT) market include Illumina, Inc. (US), Natera, Inc. (US), Laboratory Corporation of America Holdings (US), Eurofins Sceintific (France), F. Hoffmann-La Roche AG (Switzerland). Revvity, Inc. (US), Thermo Fisher Scientific Inc (US), Agilent Technologies (US), GE Healthcare Technologies Inc. (US), Quest Diagnostics Incorporated (US), Sonic Healthcare Limited (Australia), Centogene N.V. (Germany), Qiagen N.V. (Germany), Pathwest Laboratory Medicine WA (Australia), Myriad Genetics Inc. (US), BGI Genomics Co., Ltd. (China), Oxford Nanopore Technologies Plc. (UK), Medgenome (India), Neuberg Diagnostics (India), Anngroad Gene Technology (China), Next Biosciences (South Africa), Lilac Insights (India), Invitae Corporation (US), Baylor Genetics (US), Raven (US).

Research Coverage:

The market analysis examines the non-invasive prenatal testing (NIPT) market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product and service, method type, application type, end user type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the non-invasive prenatal testing (NIPT) market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.

This report provides insights into the following pointers:

  • Analysis of key Drivers: Drivers (High risk of chromosomal abnormalities with increasing maternal age, Growing preference for non-invasive techniques over invasive methods, Improving reimbursement scenario for NIPT, Programs focusing on increasing awareness of NIPT), Restrains (High cost of procedures, Lack of insurance coverage), Opportunities (Untapped emerging markets, Technological Advancements), Challenges (Reliability of test results especially in obese women, Lack of skilled professionals) influencing the growth of the non-invasive prenatal testing (NIPT) market.
  • Market Penetration: Comprehensive information on the product portfolios of the leading companies in the non-invasive prenatal testing (NIPT) market. The report breaks down the market by product and service type, method types, application types, end user types and region.
  • Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the non-invasive prenatal testing (NIPT) market.
  • Market Development: Comprehensive data on attractive rising markets broken down by product and service type, method types, application types, end user types and region.
  • Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the non-invasive prenatal testing (NIPT) market.
  • Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main non-invasive prenatal testing (NIPT) products manufacturers.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NON-INVASIVE PRENATAL TESTING MARKET OVERVIEW
  • 4.2 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
  • 4.3 GEOGRAPHIC MIX: NON-INVASIVE PRENATAL TESTING MARKET, 2024-2029 (USD MILLION)
  • 4.4 NON-INVASIVE PRENATAL TESTING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS, 2024 VS. 2029

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High risk of chromosomal abnormalities with increasing maternal age
      • 5.2.1.2 Growing preference for noninvasive techniques over invasive methods
      • 5.2.1.3 Improving reimbursement scenario
      • 5.2.1.4 Initiatives to spread awareness
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of procedures
      • 5.2.2.2 Lack of insurance coverage
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Untapped emerging markets
      • 5.2.3.2 Technological advancements
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reliability of test results
      • 5.2.4.2 Lack of skilled professionals
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 DETECTION BEYOND TRISOMIES
    • 5.3.2 EARLIER GESTATIONAL AGE TESTING
    • 5.3.3 INTEGRATION WITH NGS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Cell-free DNA analysis
      • 5.4.1.2 NGS
      • 5.4.1.3 Digital PCR
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Microfluidics
      • 5.4.2.2 Nanotechnology
      • 5.4.2.3 Epigenetics analysis
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Ultrasound imaging
      • 5.4.3.2 Genome editing (CRISPR/Cas9)
      • 5.4.3.3 Liquid biopsy
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 PORTER'S FIVE FORCE ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 BARGAINING POWER OF BUYERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.9.2 BUYING CRITERIA
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 REGULATORY ANALYSIS
    • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS
    • 5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
  • 5.13 PRICING ANALYSIS
    • 5.13.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
    • 5.13.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.14 REIMBURSEMENT ANALYSIS
  • 5.15 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.16 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.17 CASE STUDIES
    • 5.17.1 EVALUATION OF NIFTY TEST IN DETECTING FETAL CHROMOSOMAL ABNORMALITIES IN ASIAN POPULATIONS
    • 5.17.2 CLINICAL UTILITY OF HARMONY PRENATAL TEST IN A COHORT OF PREGNANT WOMEN
    • 5.17.3 ASSESSMENT OF PANORAMA TEST IN DETECTING FETAL GENETIC CONDITIONS
  • 5.18 ADJACENT MARKET ANALYSIS
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.21 IMPACT OF ARTIFICIAL INTELLIGENCE ON NON-INVASIVE PRENATAL TESTING MARKET

6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    • 6.2.1 CONSUMABLES
      • 6.2.1.1 Assay kits & reagents
        • 6.2.1.1.1 Frequent use of reagents and assay kits to drive market
      • 6.2.1.2 Disposables
        • 6.2.1.2.1 Need for contamination-free workflow to boost demand for disposables
    • 6.2.2 INSTRUMENTS
      • 6.2.2.1 Ultrasound devices
        • 6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety to drive market
      • 6.2.2.2 NGS systems
        • 6.2.2.2.1 Rising use of NGS in NIPT to drive market
      • 6.2.2.3 PCR instruments
        • 6.2.2.3.1 Increasing research in prenatal genetic testing to boost market growth
      • 6.2.2.4 Microarrays
        • 6.2.2.4.1 Flexibility of chips and short processing times to support usage
      • 6.2.2.5 Other instruments
  • 6.3 SERVICES
    • 6.3.1 NORTH AMERICA TO REGISTER HIGHEST DEMAND FOR TESTING SERVICES

7 NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD

  • 7.1 INTRODUCTION
  • 7.2 ULTRASOUND DETECTION
    • 7.2.1 ULTRASOUND DETECTION TO DOMINATE NIPT MARKET
  • 7.3 BIOCHEMICAL SCREENING TESTS
    • 7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH
  • 7.4 CFDNA IN MATERNAL PLASMA TESTS
    • 7.4.1 CFDNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER HIGHEST CAGR

8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 TRISOMY
    • 8.2.1 TRISOMY TO HOLD LARGEST SHARE OF APPLICATIONS MARKET AND SHOW HIGHEST GROWTH
  • 8.3 MICRODELETION SYNDROME
    • 8.3.1 INCREASING AWARENESS TO SUPPORT DEMAND FOR TESTING
  • 8.4 OTHER APPLICATIONS

9 NON-INVASIVE PRENATAL TESTING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 RISING RESEARCH INTENSITY TO DRIVE USAGE OF NIPT PRODUCTS IN DIAGNOSTIC LABS
  • 9.3 HOSPITALS
    • 9.3.1 RISING INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO PROPEL MARKET

10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 10.2.2 US
      • 10.2.2.1 High incidence of chromosomal syndromes to drive demand
    • 10.2.3 CANADA
      • 10.2.3.1 Unfavorable reimbursement scenario for NIPT to challenge market growth
  • 10.3 EUROPE
    • 10.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 10.3.2 UK
      • 10.3.2.1 High incidence of genetic abnormalities to increase demand for prenatal testing
    • 10.3.3 GERMANY
      • 10.3.3.1 Strong R&D and increasing healthcare spending to drive market
    • 10.3.4 FRANCE
      • 10.3.4.1 Favorable insurance coverage for prenatal testing to increase adoption of NIPT
    • 10.3.5 ITALY
      • 10.3.5.1 Favorable funding scenario for genomics to drive market
    • 10.3.6 SPAIN
      • 10.3.6.1 Rising funding and expanding research infrastructure to propel market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising maternal age to propel incidence of chromosomal disorders
    • 10.4.3 CHINA
      • 10.4.3.1 China to register highest growth in Asia Pacific market
    • 10.4.4 INDIA
      • 10.4.4.1 Rising disposable income and demand for better health to support market growth
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Strong research ecosystem for NIPT to drive market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Increasing scope for genomic research to support market growth
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 10.5.2 BRAZIL
      • 10.5.2.1 Rising focus on clinical genomics to drive demand for NIPT
    • 10.5.3 MEXICO
      • 10.5.3.1 High incidence of Down syndrome to propel demand
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Launch of genomic initiatives to drive market
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NON-INVASIVE PRENATAL TESTING MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 R&D EXPENDITURE OF KEY PLAYERS
  • 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • 11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.6.5.1 Company footprint
      • 11.6.5.2 Product & service footprint
      • 11.6.5.3 Method footprint
      • 11.6.5.4 Application footprint
      • 11.6.5.5 End-user footprint
      • 11.6.5.6 Region footprint
  • 11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 DYNAMIC COMPANIES
    • 11.7.3 STARTING BLOCKS
    • 11.7.4 RESPONSIVE COMPANIES
    • 11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.8 VALUATION & FINANCIAL METRICS
  • 11.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT & SERVICE LAUNCHES
    • 11.10.2 DEALS
    • 11.10.3 EXPANSIONS
    • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 ILLUMINA, INC.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products & services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches & approvals
        • 12.1.1.3.2 Expansions
        • 12.1.1.3.3 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 NATERA, INC.
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products & services offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product & service launches and approvals
        • 12.1.2.3.2 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products & services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 EUROFINS SCIENTIFIC
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products & services offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Service launches
        • 12.1.4.3.2 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 F. HOFFMANN-LA ROCHE AG
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products & services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 REVVITY, INC.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products & services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches
        • 12.1.6.3.2 Deals
    • 12.1.7 THERMO FISHER SCIENTIFIC INC.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products & services offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
    • 12.1.8 AGILENT TECHNOLOGIES
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products & services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
    • 12.1.9 GE HEALTHCARE TECHNOLOGIES INC.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products & services offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Product & service launches and approvals
        • 12.1.9.3.2 Expansions
    • 12.1.10 QUEST DIAGNOSTICS INCORPORATED
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products & services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product launches
        • 12.1.10.3.2 Deals
    • 12.1.11 SONIC HEALTHCARE LIMITED
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products & services offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Deals
        • 12.1.11.3.2 Expansions
    • 12.1.12 CENTOGENE N.V.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products & services offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Product launches
        • 12.1.12.3.2 Deals
        • 12.1.12.3.3 Other developments
    • 12.1.13 QIAGEN N.V.
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products & services offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Product launches
        • 12.1.13.3.2 Deals
        • 12.1.13.3.3 Expansions
    • 12.1.14 PATHWEST LABORATORY MEDICINE WA
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products & services offered
    • 12.1.15 MYRIAD GENETICS, INC.
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products & services offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 BGI GENOMICS CO., LTD.
    • 12.2.2 OXFORD NANOPORE TECHNOLOGIES PLC
    • 12.2.3 MEDGENOME
    • 12.2.4 NEUBERG DIAGNOSTICS
    • 12.2.5 ANNOROAD GENE TECHNOLOGY
    • 12.2.6 NEXT BIOSCIENCES
    • 12.2.7 LILAC INSIGHTS
    • 12.2.8 INVITAE CORPORATION
    • 12.2.9 BAYLOR GENETICS
    • 12.2.10 RAVGEN

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE
  • TABLE 3 INCIDENCE RATE OF TRISOMY
  • TABLE 4 COMPARISON OF NONINVASIVE AND INVASIVE PRENATAL TESTING
  • TABLE 5 NIPT REIMBURSEMENT SCENARIO, BY COUNTRY
  • TABLE 6 PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)
  • TABLE 7 NIPT MARKET: ECOSYSTEM ANALYSIS
  • TABLE 8 NIPT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS
  • TABLE 10 KEY BUYING CRITERIA FOR NIPT PRODUCTS
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 LIST OF PATENTS IN NIPT MARKET, 2014-2024
  • TABLE 17 IMPORT AND EXPORT DATA FOR NEXT-GENERATION SEQUENCING PRODUCTS, BY COUNTRY
  • TABLE 18 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY TYPE
  • TABLE 19 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY REGION
  • TABLE 20 NIPT MARKET: LIST OF KEY CONFERENCES AND EVENTS DURING 2024-2025
  • TABLE 21 NIPT MARKET: UNMET NEEDS
  • TABLE 22 NIPT MARKET: END-USER EXPECTATIONS
  • TABLE 23 NIPT MARKET: IMPACT AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE
  • TABLE 24 NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 25 NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 26 NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 27 NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 28 NIPT PRODUCTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 29 NIPT PRODUCTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 30 NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 31 NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 32 NIPT CONSUMABLES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 33 NIPT CONSUMABLES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 34 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 35 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 36 DISPOSABLES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 37 DISPOSABLES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 38 NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 39 NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 40 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 41 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 42 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 43 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 44 NGS SYSTEMS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 45 NGS SYSTEMS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 46 PCR INSTRUMENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 47 PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 48 MICROARRAYS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 49 MICROARRAYS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 50 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 51 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 52 NIPT SERVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 53 NIPT SERVICES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 54 NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 55 NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 56 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 57 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 58 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 59 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 60 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 61 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 62 NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 63 NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 64 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 65 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 66 NIPT MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 67 NIPT MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 68 NIPT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 69 NIPT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 70 NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 71 NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 72 NIPT MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 73 NIPT MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 74 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 75 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 76 NIPT MARKET, BY REGION, 2021-2023 (USD MILLION)
  • TABLE 77 NIPT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 79 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 81 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 83 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 85 NORTH AMERICA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 87 NORTH AMERICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 89 NORTH AMERICA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 91 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 93 NORTH AMERICA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 94 US: KEY MACROINDICATORS
  • TABLE 95 US: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 96 US: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 97 US: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 98 US: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 99 US: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 100 US: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 101 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 102 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 103 US: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 104 US: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 105 US: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 106 US: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 107 US: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 108 US: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 109 CANADA: KEY MACROINDICATORS
  • TABLE 110 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 111 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 112 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 113 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 114 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 115 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 116 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 117 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 118 CANADA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 119 CANADA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 120 CANADA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 121 CANADA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 122 CANADA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 123 CANADA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 124 EUROPE: NIPT MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 125 EUROPE: NIPT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 126 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 127 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 128 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 129 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 130 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 131 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 132 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 133 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 134 EUROPE: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 135 EUROPE: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 136 EUROPE: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 137 EUROPE: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 138 EUROPE: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 139 EUROPE: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 140 UK: KEY MACROINDICATORS
  • TABLE 141 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 142 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 143 UK: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 144 UK: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 145 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 146 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 147 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 148 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 149 UK: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 150 UK: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 151 UK: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 152 UK: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 153 UK: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 154 UK: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 155 GERMANY: KEY MACROINDICATORS
  • TABLE 156 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 157 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 158 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 159 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 160 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 161 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 162 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 163 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 164 GERMANY: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 165 GERMANY: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 166 GERMANY: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 167 GERMANY: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 168 GERMANY: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 169 GERMANY: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 170 FRANCE: KEY MACROINDICATORS
  • TABLE 171 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 172 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 173 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 174 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 175 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 176 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 177 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 178 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 179 FRANCE: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 180 FRANCE: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 181 FRANCE: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 182 FRANCE: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 183 FRANCE: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 184 FRANCE: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 185 ITALY: KEY MACROINDICATORS
  • TABLE 186 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 187 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 188 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 189 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 190 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 191 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 192 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 193 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 194 ITALY: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 195 ITALY: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 196 ITALY: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 197 ITALY: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 198 ITALY: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 199 ITALY: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 200 SPAIN: KEY MACROINDICATORS
  • TABLE 201 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 202 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 203 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 204 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 205 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 206 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 207 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 208 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 209 SPAIN: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 210 SPAIN: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 211 SPAIN: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 212 SPAIN: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 213 SPAIN: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 214 SPAIN: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 215 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 216 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 217 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 218 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 219 REST OF EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 220 REST OF EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 221 REST OF EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 222 REST OF EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 223 REST OF EUROPE: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 224 REST OF EUROPE: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 225 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 226 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 227 REST OF EUROPE: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 228 REST OF EUROPE: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 229 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 230 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 231 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 232 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 233 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 234 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 245 JAPAN: KEY MACROINDICATORS
  • TABLE 246 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 247 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 248 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 249 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 250 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 251 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 252 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 253 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 254 JAPAN: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 255 JAPAN: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 256 JAPAN: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 257 JAPAN: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 258 JAPAN: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 259 JAPAN: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 260 CHINA: KEY MACROINDICATORS
  • TABLE 261 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 262 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 263 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 264 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 265 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 266 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 267 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 268 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 269 CHINA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 270 CHINA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 271 CHINA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 272 CHINA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 273 CHINA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 274 CHINA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 275 INDIA: KEY MACROINDICATORS
  • TABLE 276 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 277 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 278 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 279 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 280 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 281 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 282 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 283 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 284 INDIA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 285 INDIA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 286 INDIA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 287 INDIA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 288 INDIA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 289 INDIA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 290 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 291 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 292 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 293 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 294 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 295 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 296 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 297 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 298 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 299 AUSTRALIA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 300 AUSTRALIA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 301 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 302 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 303 AUSTRALIA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 304 AUSTRALIA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 305 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 306 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 307 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 308 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 309 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 310 SOUTH KOREA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 311 SOUTH KOREA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 312 SOUTH KOREA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 313 SOUTH KOREA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 314 SOUTH KOREA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 315 SOUTH KOREA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 316 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 317 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 318 SOUTH KOREA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 319 SOUTH KOREA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 320 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 321 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 322 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 323 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 324 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 325 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 326 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 327 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 328 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 329 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 330 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 331 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 332 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 333 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 334 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 335 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 336 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 337 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 338 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 339 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 340 LATIN AMERICA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 341 LATIN AMERICA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 342 LATIN AMERICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 343 LATIN AMERICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 344 LATIN AMERICA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 345 LATIN AMERICA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 346 LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 347 LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 348 LATIN AMERICA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 349 LATIN AMERICA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 350 BRAZIL: KEY MACROINDICATORS
  • TABLE 351 BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 352 BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 353 BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 354 BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 355 BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 356 BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 357 BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 358 BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 359 BRAZIL: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 360 BRAZIL: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 361 BRAZIL: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 362 BRAZIL: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 363 BRAZIL: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 364 BRAZIL: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 365 MEXICO: KEY MACROINDICATORS
  • TABLE 366 MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 367 MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 368 MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 369 MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 370 MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 371 MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 372 MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 373 MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 374 MEXICO: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 375 MEXICO: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 376 MEXICO: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 377 MEXICO: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 378 MEXICO: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 379 MEXICO: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 381 REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 382 REST OF LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 383 REST OF LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 384 REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 385 REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 386 REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 387 REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 388 REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 389 REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 390 REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 391 REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 392 REST OF LATIN AMERICA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 393 REST OF LATIN AMERICA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 394 MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2021-2023 (USD MILLION)
  • TABLE 395 MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 396 MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 397 MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 398 MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 399 MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 400 MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 401 MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 402 MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 403 MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 404 MIDDLE EAST & AFRICA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 405 MIDDLE EAST & AFRICA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 406 MIDDLE EAST & AFRICA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 407 MIDDLE EAST & AFRICA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 408 MIDDLE EAST & AFRICA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 409 MIDDLE EAST & AFRICA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 410 GCC COUNTRIES: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 411 GCC COUNTRIES: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 412 GCC COUNTRIES: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 413 GCC COUNTRIES: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 414 GCC COUNTRIES: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 415 GCC COUNTRIES: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 416 GCC COUNTRIES: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 417 GCC COUNTRIES: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 418 GCC COUNTRIES: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 419 GCC COUNTRIES: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 420 GCC COUNTRIES: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 421 GCC COUNTRIES: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 423 GCC COUNTRIES: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 424 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE, 2021-2023 (USD MILLION)
  • TABLE 425 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE, 2024-2029 (USD MILLION)
  • TABLE 426 REST OF MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 427 REST OF MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 428 REST OF MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 429 REST OF MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 430 REST OF MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 431 REST OF MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 432 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY METHOD, 2021-2023 (USD MILLION)
  • TABLE 433 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY METHOD, 2024-2029 (USD MILLION)
  • TABLE 434 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 435 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 436 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 437 REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY END USER, 2024-2029 (USD MILLION)
  • TABLE 438 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS
  • TABLE 439 NIPT MARKET: DEGREE OF COMPETITION
  • TABLE 440 NIPT MARKET: PRODUCT & SERVICE FOOTPRINT
  • TABLE 441 NIPT MARKET: METHOD FOOTPRINT
  • TABLE 442 NIPT MARKET: APPLICATION FOOTPRINT
  • TABLE 443 NIPT MARKET: END-USER FOOTPRINT
  • TABLE 444 NIPT MARKET: REGION FOOTPRINT
  • TABLE 445 NIPT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 446 NIPT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING STARTUPS/SMES
  • TABLE 447 NIPT MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 448 NIPT MARKET: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 449 NIPT MARKET: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 450 NIPT MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 451 ILLUMINA: COMPANY OVERVIEW
  • TABLE 452 ILLUMINA: PRODUCTS & SERVICES OFFERED
  • TABLE 453 ILLUMINA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 454 ILLUMINA: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 455 ILLUMINA: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 456 NATERA: COMPANY OVERVIEW
  • TABLE 457 NATERA: PRODUCTS & SERVICES OFFERED
  • TABLE 458 NATERA: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 459 NATERA: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 460 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
  • TABLE 461 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS & SERVICES OFFERED
  • TABLE 462 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 463 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 464 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
  • TABLE 465 EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 466 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 467 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
  • TABLE 468 F. HOFFMANN-LA ROCHE: PRODUCTS & SERVICES OFFERED
  • TABLE 469 F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 470 F. HOFFMANN-LA ROCHE: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 471 REVVITY: COMPANY OVERVIEW
  • TABLE 472 REVVITY: PRODUCTS & SERVICES OFFERED
  • TABLE 473 REVVITY: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 474 REVVITY: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 475 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 476 THERMO FISHER SCIENTIFIC: PRODUCTS & SERVICES OFFERED
  • TABLE 477 THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 478 AGILENT TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 479 AGILENT TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
  • TABLE 480 AGILENT TECHNOLOGIES: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 481 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 482 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED
  • TABLE 483 GE HEALTHCARE: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 484 GE HEALTHCARE: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 485 QUEST DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 486 QUEST DIAGNOSTICS: PRODUCTS & SERVICES OFFERED
  • TABLE 487 QUEST DIAGNOSTICS: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 488 QUEST DIAGNOSTICS: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 489 SONIC HEALTHCARE: COMPANY OVERVIEW
  • TABLE 490 SONIC HEALTHCARE: PRODUCTS & SERVICES OFFERED
  • TABLE 491 SONIC HEALTHCARE: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 492 SONIC HEALTHCARE: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 493 CENTOGENE: COMPANY OVERVIEW
  • TABLE 494 CENTOGENE: PRODUCTS & SERVICES OFFERED
  • TABLE 495 CENTOGENE: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 496 CENTOGENE: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 497 CENTOGENE: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 498 QIAGEN: COMPANY OVERVIEW
  • TABLE 499 QIAGEN: PRODUCTS & SERVICES OFFERED
  • TABLE 500 QIAGEN: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 501 QIAGEN: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 502 QIAGEN: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 503 PATHWEST LABORATORY MEDICINE: COMPANY OVERVIEW
  • TABLE 504 PATHWEST LABORATORY MEDICINE: PRODUCTS & SERVICES OFFERED
  • TABLE 505 MYRIAD GENETICS: COMPANY OVERVIEW
  • TABLE 506 MYRIAD GENETICS: PRODUCTS & SERVICES OFFERED

List of Figures

  • FIGURE 1 NIPT MARKET SEGMENTATION
  • FIGURE 2 NIPT MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 6 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 7 TOP-DOWN APPROACH
  • FIGURE 8 BOTTOM-UP APPROACH
  • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 SERVICES SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 13 CONSUMABLES TO HOLD LARGEST SHARE OF PRODUCTS MARKET
  • FIGURE 14 DISPOSABLES SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 15 NGS SYSTEMS TO REGISTER HIGHEST GROWTH IN INSTRUMENTS MARKET
  • FIGURE 16 ULTRASOUND DETECTION SEGMENT TO HOLD LARGEST MARKET SHARE
  • FIGURE 17 TRISOMY TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 18 DIAGNOSTIC LABORATORIES TO DOMINATE END-USER MARKET
  • FIGURE 19 NORTH AMERICA AND EUROPE ACCOUNTED FOR LARGEST MARKET SHARES IN 2023
  • FIGURE 20 HIGH RISK OF CHROMOSOMAL ABNORMALITIES WITH INCREASING MATERNAL AGE TO DRIVE ADOPTION
  • FIGURE 21 TRISOMY HELD LARGEST SHARE OF EUROPEAN MARKET IN 2023
  • FIGURE 22 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 24 NIPT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 INTEGRATION WITH NGS-A LEADING TREND IN NIPT
  • FIGURE 26 VALUE CHAIN ANALYSIS OF NIPT MARKET: R&D AND MANUFACTURING PHASE ADD MAXIMUM VALUE
  • FIGURE 27 NIPT MARKET: ECOSYSTEM
  • FIGURE 28 NIPT MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 NIPT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS
  • FIGURE 31 KEY BUYING CRITERIA FOR NIPT PRODUCTS
  • FIGURE 32 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2014-JUNE 2024)
  • FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR NIPT PATENTS (JANUARY 2014- JUNE 2024)
  • FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR NIPT (JANUARY 2014- JUNE 2024)
  • FIGURE 35 OVERVIEW OF ADJACENT MARKETS TO NIPT
  • FIGURE 36 NIPT MARKET: INVESTMENT & FUNDING SCENARIO (2019-2023)
  • FIGURE 37 REVENUE SHIFTS IN NIPT MARKET
  • FIGURE 38 NIPT MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 39 NORTH AMERICA: NIPT MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF TOP PLAYERS IN NIPT MARKET (2021-2023)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN NIPT MARKET (2023)
  • FIGURE 43 R&D EXPENDITURE OF KEY PLAYERS IN NIPT, 2021-2023
  • FIGURE 44 NIPT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 NIPT MARKET: COMPANY FOOTPRINT
  • FIGURE 46 NIPT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 EV/EBITDA OF KEY PLAYERS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 ILLUMINA: COMPANY SNAPSHOT (2023)
  • FIGURE 50 NATERA: COMPANY SNAPSHOT (2023)
  • FIGURE 51 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023)
  • FIGURE 52 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 53 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2023)
  • FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023)
  • FIGURE 55 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 56 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2023)
  • FIGURE 57 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 58 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023)
  • FIGURE 59 SONIC HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 60 CENTOGENE: COMPANY SNAPSHOT (2023)
  • FIGURE 61 QIAGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 62 PATHWEST LABORATORY MEDICINE: COMPANY SNAPSHOT (2023)
  • FIGURE 63 MYRIAD GENETICS: COMPANY SNAPSHOT (2023)